We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$618M
AUM Growth
-$43.1M
Cap. Flow
-$63.8M
Cap. Flow %
-10.32%
Top 10 Hldgs %
7.4%
Holding
973
New
156
Increased
203
Reduced
222
Closed
372

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$3.94M
2
MRSH
Marsh
MRSH
+$3.18M
3
DXC icon
DXC Technology
DXC
+$3.13M
4
WAT icon
Waters Corp
WAT
+$3.01M
5
DPZ icon
Domino's
DPZ
+$2.73M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$3.17M
2
ATKR icon
Atkore
ATKR
+$3.17M
3
ANET icon
Arista Networks
ANET
+$3.02M
4
ENPH icon
Enphase Energy
ENPH
+$3M
5
EVH icon
Evolent Health
EVH
+$2.97M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Healthcare 18.83%
3 Financials 14.91%
4 Industrials 13.43%
5 Consumer Discretionary 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
51
Genpact
G
$5.53B
$2.54M 0.41%
54,731
+26,575
+94% +$1.21M
QGEN icon
52
Qiagen
QGEN
$8.5B
$2.52M 0.41%
+47,661
New +$2.35M
INMD icon
53
InMode
INMD
$889M
$2.51M 0.41%
70,252
+51,320
+271% +$1.79M
ALB icon
54
Albemarle
ALB
$13.6B
$2.5M 0.4%
11,526
-6,361
-36% -$1.7M
CMBT
55
CMB.TECH NV
CMBT
$4.46B
$2.46M 0.4%
144,227
+114,636
+387% +$2.07M
AGL icon
56
Agilon Health
AGL
$1.6B
$2.45M 0.4%
6,081
-239
-4% -$112K
SGEN
57
DELISTED
Seagen Inc. Common Stock
SGEN
$2.44M 0.4%
18,998
+12,560
+195% +$1.62M
PTCT icon
58
PTC Therapeutics
PTCT
$6.3B
$2.4M 0.39%
62,895
-7,684
-11% -$319K
MASI
59
DELISTED
Masimo
MASI
$2.38M 0.38%
16,055
-7,414
-32% -$1.02M
SMCI icon
60
Super Micro Computer
SMCI
$18.7B
$2.36M 0.38%
288,000
-144,990
-33% -$1.1M
KGC icon
61
Kinross Gold
KGC
$28.3B
$2.36M 0.38%
577,370
+389,100
+207% +$1.54M
WTFC icon
62
Wintrust Financial
WTFC
$10.8B
$2.35M 0.38%
27,793
+8,433
+44% +$745K
GH icon
63
Guardant Health
GH
$19.2B
$2.34M 0.38%
+86,159
New +$3.94M
TOST icon
64
Toast
TOST
$17.8B
$2.33M 0.38%
129,485
+34,731
+37% +$653K
DKS icon
65
Dick's Sporting Goods
DKS
$18.4B
$2.31M 0.37%
+19,217
New +$2.17M
AXNX
66
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.28M 0.37%
36,471
-1,822
-5% -$121K
HWM icon
67
Howmet Aerospace
HWM
$114B
$2.27M 0.37%
57,514
-24,212
-30% -$882K
LAZ icon
68
Lazard
LAZ
$4.19B
$2.26M 0.37%
65,303
+44,121
+208% +$1.57M
PATH icon
69
UiPath
PATH
$6.02B
$2.26M 0.37%
177,440
-16,264
-8% -$201K
TDS icon
70
Telephone and Data Systems
TDS
$3.84B
$2.24M 0.36%
213,358
+160,564
+304% +$1.99M
NVRO
71
DELISTED
NEVRO CORP.
NVRO
$2.21M 0.36%
55,715
+22,728
+69% +$945K
CROX icon
72
Crocs
CROX
$6.63B
$2.16M 0.35%
19,900
+15,344
+337% +$1.36M
AMP icon
73
Ameriprise Financial
AMP
$47.3B
$2.12M 0.34%
6,822
-1,070
-14% -$326K
PTC icon
74
PTC
PTC
$14.5B
$2.11M 0.34%
+17,596
New +$2.11M
SILK
75
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$2.11M 0.34%
39,917
+32,131
+413% +$1.56M

Similar funds

PDT Partners's Q4 2022 Portfolio in Review

As of Q4 2022, PDT Partners held 973 positions worth $618M, down 6.5% from $661M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

PDT Partners withdrew a net $63.8M in Q4 2022, closing 372 positions and reducing 222 holdings. Its most notable exit was Honeywell, an estimated $3.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Guardant Health worth $2.34M.

  • PDT Partners's largest Q4 2022 buy was Guardant Health: 86,159 shares worth $2.34M.
  • PDT Partners added most to Waters Corp in Q4 2022, an estimated $3.01M increase.
  • PDT Partners's biggest Q4 2022 reduction was Enphase Energy, cutting an estimated $3M.
  • PDT Partners fully exited Honeywell in Q4 2022, selling an estimated $3.17M.
  • PDT Partners's ten largest holdings make up 7.4% of its $618M portfolio in Q4 2022.
  • PDT Partners opened 156 new positions and closed 372 in Q4 2022.
  • PDT Partners's portfolio value fell 6.5% quarter-over-quarter to $618M.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.